Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Parasiticidal activity of human alpha-defensin-5 against Toxoplasma gondii.

Tanaka T, Rahman MM, Battur B, Boldbaatar D, Liao M, Umemiya-Shirafuji R, Xuan X, Fujisaki K.

In Vitro Cell Dev Biol Anim. 2010 Jun;46(6):560-5. doi: 10.1007/s11626-009-9271-9. Epub 2010 Feb 5.

PMID:
20135360
2.

Parasiticidal activity of Haemaphysalis longicornis longicin P4 peptide against Toxoplasma gondii.

Tanaka T, Maeda H, Matsuo T, Boldbattar D, Umemiya-Shirafuji R, Kume A, Suzuki H, Xuan X, Tsuji N, Fujisaki K.

Peptides. 2012 Mar;34(1):242-50. doi: 10.1016/j.peptides.2011.07.027. Epub 2011 Aug 9.

PMID:
21849158
3.

Parasiticidal activity of bovine lactoperoxidase against Toxoplasma gondii.

Tanaka T, Murakami S, Kumura H, Igarashi I, Shimazaki K.

Biochem Cell Biol. 2006 Oct;84(5):774-9.

PMID:
17167541
4.

Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction.

Madison MN, Kleshchenko YY, Nde PN, Simmons KJ, Lima MF, Villalta F.

Infect Immun. 2007 Oct;75(10):4780-91. Epub 2007 Jul 16.

5.

Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii.

Basto AP, Müller J, Rubbiani R, Stibal D, Giannini F, Süss-Fink G, Balmer V, Hemphill A, Gasser G, Furrer J.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01031-17. doi: 10.1128/AAC.01031-17. Print 2017 Sep.

6.

Unmethylated CpG motifs in Toxoplasma gondii DNA induce TLR9- and IFN-β-dependent expression of α-defensin-5 in intestinal epithelial cells.

Santamaria MH, Perez Caballero E, Corral RS.

Parasitology. 2016 Jan;143(1):60-8. doi: 10.1017/S0031182015001456. Epub 2015 Nov 2.

PMID:
26522645
7.

Dynamin inhibitor impairs Toxoplasma gondii invasion.

Caldas LA, Attias M, de Souza W.

FEMS Microbiol Lett. 2009 Nov;301(1):103-8. doi: 10.1111/j.1574-6968.2009.01799.x. Epub 2009 Sep 21.

8.

In vitro antagonistic and indifferent activity of combination of 3-deoxyanthocyanidins against Toxoplasma gondii.

Abugri DA, Witola WH, Jaynes JM.

Parasitol Res. 2017 Dec;116(12):3387-3400. doi: 10.1007/s00436-017-5661-1. Epub 2017 Oct 30.

PMID:
29086004
9.

Cellular response to Trypanosoma cruzi infection induces secretion of defensin α-1, which damages the flagellum, neutralizes trypanosome motility, and inhibits infection.

Johnson CA, Rachakonda G, Kleshchenko YY, Nde PN, Madison MN, Pratap S, Cardenas TC, Taylor C, Lima MF, Villalta F.

Infect Immun. 2013 Nov;81(11):4139-48. doi: 10.1128/IAI.01459-12. Epub 2013 Aug 26.

10.

Effect of nitaxozanide and pyrimethamine on astrocytes infected by Toxoplasma gondii in vitro.

Galván-Ramírez Mde L, Dueñas Jiménez JM, Rocío Rodríguez Pérez L, Troyo-Sanroman R, Ramírez-Herrera M, García-Iglesias T.

Arch Med Res. 2013 Aug;44(6):415-21. doi: 10.1016/j.arcmed.2013.07.002. Epub 2013 Aug 22.

PMID:
23973195
11.

Afatinib Reduces STAT6 Signaling of Host ARPE-19 Cells Infected with Toxoplasma gondii.

Yang Z, Ahn HJ, Park YH, Nam HW.

Korean J Parasitol. 2016 Feb;54(1):31-8. doi: 10.3347/kjp.2016.54.1.31. Epub 2016 Feb 26.

12.

In vitro action of antiparasitic drugs, especially artesunate, against Toxoplasma gondii.

Gomes TC, de Andrade Júnior HF, Lescano SA, Amato-Neto V.

Rev Soc Bras Med Trop. 2012 Jul-Aug;45(4):485-90.

14.

A4D12 monoclonal antibody recognizes a new linear epitope from SAG2A Toxoplasma gondii tachyzoites, identified by phage display bioselection.

Cunha-Júnior JP, Silva DA, Silva NM, Souza MA, Souza GR, Prudencio CR, Pirovani CP, Cezar M Cascardo J, Barbosa BF, Goulart LR, Mineo JR.

Immunobiology. 2010;215(1):26-37. doi: 10.1016/j.imbio.2009.01.008. Epub 2009 Mar 3.

PMID:
19261354
15.

Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.

Dzitko K, Grzybowski MM, Pawełczyk J, Dziadek B, Gatkowska J, Stączek P, Długońska H.

Parasit Vectors. 2015 Aug 15;8:422. doi: 10.1186/s13071-015-1019-7.

16.

In Vitro Effect of the Synthetic cal14.1a Conotoxin, Derived from Conus californicus, on the Human Parasite Toxoplasma gondii.

De León-Nava MA, Romero-Núñez E, Luna-Nophal A, Bernáldez-Sarabia J, Sánchez-Campos LN, Licea-Navarro AF, Morales-Montor J, Muñiz-Hernández S.

Mar Drugs. 2016 Apr 8;14(4). pii: E66. doi: 10.3390/md14040066.

17.

Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.

Meng M, He S, Zhao G, Bai Y, Zhou H, Cong H, Lu G, Zhao Q, Zhu XQ.

Parasit Vectors. 2012 Nov 26;5:273. doi: 10.1186/1756-3305-5-273.

18.

Modulation of early β-defensin-2 production as a mechanism developed by type I Toxoplasma gondii to evade human intestinal immunity.

Morampudi V, Braun MY, D'Souza S.

Infect Immun. 2011 May;79(5):2043-50. doi: 10.1128/IAI.01086-10. Epub 2011 Mar 7.

19.

[Comparison of Immune Responses Elicited by Adjuvanted Tachyzoite Lysate Vaccines Developed from Two Different Toxoplasma gondii Strains Isolated in Turkey].

Polat C, Gülçe İz S, Döşkaya M, Can H, Caner A, Değirmenci A, Balcan E, Gürüz Y.

Mikrobiyol Bul. 2013 Jan;47(1):122-34. Turkish.

20.

A new type of quinoxalinone derivatives affects viability, invasion, and intracellular growth of Toxoplasma gondii tachyzoites in vitro.

Rivera Fernández N, Mondragón Castelán M, González Pozos S, Ramírez Flores CJ, Mondragón González R, Gómez de León CT, Castro Elizalde KN, Marrero Ponce Y, Arán VJ, Martins Alho MA, Mondragón Flores R.

Parasitol Res. 2016 May;115(5):2081-96. doi: 10.1007/s00436-016-4953-1. Epub 2016 Feb 18.

PMID:
26888289

Supplemental Content

Support Center